Inhibitors of the renin-angiotensin-aldosterone system (RAAS) have been shown to be not only cardio protective but in addition exhibit particular nephro protective effects in patients with diabetic kidney disease [5, 7]. This evidence concerns the gene REN and diabetic kidney disease.